Is PRTK A Good Stock To Buy Now?
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
Paratek Pharmaceuticals Inc. (PRTK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 35,615,000 | $31,948 | 0.74% | ||
| 2. | 12,521,000 | $11,079 | +8% | 0.34% | |
| 3. | AIGH Investment Partners Orin Hirschman | 3,139,714 | $9,325 | +35% | 2.28% |
| 4. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 1,726,637 | $5,128 | +2% | 0.12% |
| 5. | Fortress Investment Group Michael Novogratz | 942,258 | $2,798 | 0.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.00 | 76,923 | Director | 1,187,365 | 2016-06-27 | Filing | |
| $13.00 | 384,615 | Director | 779,802 | 2016-06-27 | Filing | |
| $13.00 | 384,615 | Large Shareholder | 779,802 | 2016-06-27 | Filing | |
| $13.00 | 76,923 | Large Shareholder | 1,187,365 | 2016-06-27 | Filing | |
| $13.45 | 20,000 | Officer, Director | 100,000 | 2016-06-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.27 | 17,819 | Officer, Director | 890,782 | 2021-12-15 | Filing | |
| $4.37 | 8,622 | Officer, Director | 908,601 | 2021-12-14 | Filing | |
| $4.42 | 5,059 | Officer, Director | 917,223 | 2021-12-13 | Filing | |
| $4.27 | 15,780 | Officer | 253,530 | 2021-12-15 | Filing | |
| $4.37 | 7,635 | Officer | 269,310 | 2021-12-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | Ubs Oconnor LlcBOND | 25,000,000 | $22,073,000 | 0.47% |
| 2. | 40,924 | $121,544 | 0% | |
| 3. | 20,060,000 | $22,713 | 5.56% | |
| 4. | 16,600,000 | $14,608 | 2.98% | |
| 5. | 2,940,513 | $8,734 | 0% |
News See All
Should You Avoid Paratek Pharmaceuticals Inc (PRTK)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is Paratek Pharmaceuticals Inc (PRTK) Going to Burn These Hedge Funds?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Here’s What Hedge Funds Think About Paratek Pharmaceuticals Inc (PRTK)
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter.
Arbiter Partners Capital Management’s Returns, AUM and Holdings
Paul J. Isaac's Arbiter Partners Capital Management LLC is an employee-owned, New York-based hedge fund, founded back in January 2001.
Hedge Funds Are Selling Paratek Pharmaceuticals Inc (PRTK)
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns.
Hedge Fund and Insider Trading News: Steven Cohen, Ray Dalio, David Einhorn, Novocure Ltd (NVCR), USANA Health Sciences, Inc. (USNA), and More
Steven Cohen is having a tough time getting U.K. financial regulators to give him a second chance in that country.
Jim Roumell’s Views on Paratek Pharmaceuticals Inc. (PRTK)
It is unusual for us to comment on a particular company event during a quarter.
Why Paratek Pharmaceuticals Inc (PRTK) is Surging
Paratek Pharmaceuticals Inc (NASDAQ:PRTK) shares have surged over 30% in after-hours after the company reported positive results from a phase 3 study of Omadacycline in community-acquired bacterial...
Billionaire Hedge Funds
